Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison Lyons

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Neuroimmunology|March 10, 2023
Painless progressive mononeuritis multiplex secondary to AML associated neuroleukemiosisSai Nagaratnam, Nimalan Harinesan, Rajiv Wijesinghe, et al.
Journal of Hepatology|July 8, 2015
Next-generation sequencing: Application of a novel platform to analyze atypical iron disordersCameron J McDonald, Lesa Ostini, Daniel F Wallace, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs?Elizabeth A Richey, E Alison Lyons, Jonathan R Nebeker, et al.
Blood|August 16, 2005
Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) ProjectCharles L Bennett, Denis Cournoyer, Kenneth R Carson, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Neuroimmunology|March 10, 2023
Painless progressive mononeuritis multiplex secondary to AML associated neuroleukemiosisSai Nagaratnam, Nimalan Harinesan, Rajiv Wijesinghe, et al.
Journal of Hepatology|July 8, 2015
Next-generation sequencing: Application of a novel platform to analyze atypical iron disordersCameron J McDonald, Lesa Ostini, Daniel F Wallace, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs?Elizabeth A Richey, E Alison Lyons, Jonathan R Nebeker, et al.
Blood|August 16, 2005
Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) ProjectCharles L Bennett, Denis Cournoyer, Kenneth R Carson, et al.
Pageof 1